Navigation Links
Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival
Date:7/20/2009

Considerably higher risk of follicular lymphoma-related death in poorer neighborhoods may be linked to care required to address waxing and waning progression of disease

FREMONT, Calif., July 20 /PRNewswire-USNewswire/ -- The Northern California Cancer Center (NCCC) recently found that lower socioeconomic status is "significantly associated with substantially poorer survival" of follicular lymphoma in California.

Although survival rates for lymphomas have improved in recent years, not all groups are experiencing improvements. The NCCC team, headed by Theresa Keegan, Ph.D., found that among all patients diagnosed with follicular lymphoma in California, those in poorer neighborhoods had as much as a 37% increased risk of death from the disease, regardless of race/ethnicity, or the stage of their disease when diagnosed. The study results were published in the Journal of Clinical Oncology, June, 2009. NCCC's research is the first to look at socioeconomic levels and survival of this form of cancer.

Follicular lymphoma, the slow-growing, most common type of non-Hodgkin lymphoma, is a cancer of the immune system and white blood cells which affects men and women equally. The cancer involves the body's lymph nodes which fight infection and disease. It begins with an enlargement of the lymph nodes and symptoms can include fever, weight loss, sweating and fatigue. It is called "follicular" lymphoma because lymph nodes seen under microscopes display unusual rounded structures called "follicles."

Follicular lymphoma is known for its waxing and waning course. It may flare up and regress a number of times over years, which would require a continuing care program. The nature of the disease could make it difficult for people who may not be able to acc
'/>"/>

SOURCE Northern California Cancer Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
2. Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
3. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
4. University of California Los Angeles Selects Velos eResearch
5. deCODE Receives California Clinical Laboratory License
6. Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in Californias Central Valley
7. California Stem Cell Agency Exaggerated Its Role in Funding Key Research
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
11. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , , NATICK, Mass. and LONDON, Nov. 20 /...tion (NYSE: BSX ) today announced that it has re...g Administration (FDA) and CE Mark approval to mar...ent for the treatment of malignant esophageal stri... with resectable or non-resectable esophageal canc...
(Date:11/20/2009)... , , FRANKLIN LAKES, N.J., Nov. 20 /PRNews...ny) (NYSE: BDX ) today announced the completion ..., Michigan-based company that develops and manufac...latforms. ,, In May 2009, BD and HandyLab annou...commercialize molecular assays on the HandyLab Jag...
(Date:11/19/2009)... , , BIRMINGHAM, Ala., Nov. 19 /PRNewswi...asdaq: BCRX ) today announced the pricing of a pu...ock at $9.75 per share, resulting in gross proceed...offered by BioCryst pursuant to an effective shelf...Securities and Exchange Commission. BioCryst has ...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Learning Takes Place When You Get Things Right 53240 1Learning Takes Place When You Get Things Right 53240 2The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 1The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 1Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 3Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 4
...linically Meaningful Primary Endpoint for Clinical...World Muscle Society,Congress -, SOUTH PLAINFIELD...ay announced promising findings in patients with D... 13th International World Muscle Society,(WMS) Con...ng the utility,of the 6-minute walk test (6MWT) as...
.... 29 Obese school-age,kids and teens can lose wei...pate in medium- to high-intensity behavioral manag...today by HHS, Agency for Healthcare,Research and Q...y behavioral management,programs studied met for m...r 6 months to 12 months. Effective programs includ...
Other Medicine Technology:PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 5Behavioral Modification Programs Help Obese Children Manage Their Weight 2Behavioral Modification Programs Help Obese Children Manage Their Weight 3
(Date:11/20/2009)... Following a recall by Unilever The...sale Shedd,s Country Crock ® Side Dishes DELU... ® Side Dishes DELUXE Four Cheese Pasta due t...wing code dates and UPCs are affected: ,, Shed...r Broccoli Rice 21 oz, UPC 027400218316, Best By N...
(Date:11/20/2009)...swire-USNewswire/ -- The American Dental Associati...stration (FDA) to establish appropriate classifica... concern about the safety of whitening products th...rofessional consultation or examination by a denti...hemically based tooth whitening or bleaching agent...
(Date:11/20/2009)...v. 20 Samuel Gladding i...hat it means to be "happy" during the holidays. As...y in family counseling and chair of the Department... says research shows that it is the pressure to be...sion during the holidays. ,, That,s why he,s ch...
(Date:11/20/2009)...vember 20 in the Journal of the National Cancer I...s that often appear in news coverage of cancer res...e media and journals to help alleviate the problem...oshin, M.D., M.S., of Center for Medicine and the ... and Clinical Practice in New Hampshire, and Barne...
(Date:11/20/2009)...0, 2009Emergency medical service (EMS) providers i...rdiac arrests each year. Only 5 to 10 percent of ...tter quality cardiopulmonary resuscitation (CPR) p...ated with better patient outcome. The Resuscitati...al research network to study prehospital treatment...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...f patients who undergo male to female sex-change s...t that complications are common, according to a st... the urology journal BJU International. , A rese...atients who had undergone surgery and 70 who took ...
...lif., Sept. 20 Cardiva Medical, Inc.,a privately ...Augustine,Lien, Chairman and CEO, will present at ...sday, September 25th in New York City. Notably, th...learance. This new product builds on the success o...
... 20 The American Red Cross,and American Heart Ass...n,that would designate the first week of June as "...utomated External Defibrillator (AED) Week." The,b...ty of CPR and AED training and use to reduce death...
...utive and Current Banfield President Succeeds Scot...PORTLAND, Ore., Sept. 19 Effective September 19, ... Officer of Banfield, The Pet,Hospital(R), succeed...,President, Chief Operating Officer and Acting CEO...
... Leader of the Global Breast Cancer Movement, Rece... DALLAS, Sept. 19 Ambassador Nancy G. Brinker, fo...largest breast cancer,organization, and recently a...bin/prnh/20070122/NYM084LOGO ) Each year, Forbes ...
...., Sept. 19 Neurobiological,Technologies, Inc. an...e,fiscal year ended June 30, 2007, included in the...tember 13, 2007, contain a going concern,qualifica...short term investments of approximately $8.9 milli...
Other Medicine News:Health News:Most patients who have male-to-female sex-change surgery are happy, despite complications 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:National CPR/AED Awareness Week Introduced in Congress 2Health News:National CPR/AED Awareness Week Introduced in Congress 3Health News:Largest Privately-Owned Veterinary Practice in the World, Banfield, the Pet Hospital(R), Appoints New Chief Executive Officer 2Health News:Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer 2Health News:Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer 3Health News:Neurobiological Technologies Reports Going Concern Qualification 2
Codmans Micro Osseous Dissection Curette
Karlin XL Magnum Cup Curette
Caspar
Kerpel
Medicine Products: